Nakama Rakuhei, Sone Miyuki, Sugawara Shunsuke, Itou Chihiro, Kimura Shintaro, Ozawa Mizuki, Oshima Takumi, Murakami Sho, Kusumoto Masahiko
Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Jpn J Radiol. 2025 Aug;43(8):1380-1385. doi: 10.1007/s11604-025-01770-0. Epub 2025 Mar 29.
Percutaneous transesophageal gastro-tubing (PTEG) is an interventional radiology technique used for enteral feeding, or drainage in malignant bowel syndrome cases, serving as an alternative to percutaneous gastrostomy. Despite its safety and effectiveness in improving quality of life, comprehensive studies on PTEG tube replacement are limited. This study aimed to investigate the cases of PTEG tube replacement.
This single-center retrospective cohort study was conducted at the National Cancer Center Hospital, Tokyo, Japan. Data were collected from patients who underwent PTEG for malignant bowel obstruction or enteral feeding and then required tube replacement between January 1, 2014 and December 31, 2023. Patient characteristics, duration of tube indwelling, PTEG tube tip position, causes of replacement, and whether dilation or re-PTEG was performed during replacement were analyzed, excluding patients who were transferred or deceased before the initial replacement. Statistical analyses were performed using the Chi-square, Fisher's exact, and Mann-Whitney U tests, with significance set at P < 0.05.
Of 236 patients who underwent PTEG, 56 required an initial tube replacement. The mean age was 55 years, with 51.8 % of patients predominantly male. The primary indication for PTEG was decompression (52 patients). The median tube indwelling duration was 31 days, with the tube tip positioned in the gastric or duodenal in 64.3 % of cases. The most frequent reason for common replacement procedures, performed in 44 patients, was tube dysfunction. Replacement due to accidental removal in 12 patients led to higher rates of dilation or re-PTEG. The duration after accidental removal significantly affected the necessity for dilation or re-PTEG.
This study on initial PTEG tube replacement in cancer patients indicated that tube dysfunction is the primary reason for replacement, and accidental removal is more likely to require dilation or re-PTEG.
经皮经食管胃造瘘术(PTEG)是一种介入放射学技术,用于肠内营养或恶性肠道综合征病例的引流,可作为经皮胃造瘘术的替代方法。尽管其在改善生活质量方面具有安全性和有效性,但关于PTEG管更换的全面研究有限。本研究旨在调查PTEG管更换的病例。
本单中心回顾性队列研究在日本东京国家癌症中心医院进行。收集了2014年1月1日至2023年12月31日期间因恶性肠梗阻或肠内营养接受PTEG治疗后需要更换导管的患者的数据。分析患者特征、导管留置时间、PTEG管尖端位置、更换原因以及更换期间是否进行扩张或再次PTEG,排除初次更换前转院或死亡的患者。采用卡方检验、Fisher精确检验和Mann-Whitney U检验进行统计分析,显著性设定为P < 0.05。
在236例行PTEG的患者中,56例需要初次更换导管。平均年龄为55岁,51.8%的患者以男性为主。PTEG的主要适应证是减压(52例患者)。导管中位留置时间为31天,64.3%的病例导管尖端位于胃或十二指肠。44例患者进行的常见更换操作最常见的原因是导管功能障碍。12例因意外拔除导致的更换导致更高的扩张或再次PTEG发生率。意外拔除后的时间显著影响扩张或再次PTEG的必要性。
这项关于癌症患者初次PTEG管更换的研究表明,导管功能障碍是更换的主要原因,意外拔除更有可能需要扩张或再次PTEG。